Aeluma, Inc.: CEO terminated Rule 10b5-1 trading arrangement

What happened Aeluma, Inc. filed a Form 8-K on Oct 22, 2026, reporting that Jonathan Klamkin, President, Chief Executive Officer and Chairman, terminated a Rule 10b5-1 trading arrangement on Oct 21, 2026. The filing notes that on May 23, 2026, Dr. Klamkin adopted the Rule 10b5-1 plan that "provided for the sale of up to 300,000 shares" of common stock.

Key details

• Filing date: Oct 22, 2026 (Form 8-K, Item 8.01 Other events).
• Adoption date of the plan: May 23, 2026.
• Plan terms: provided for the sale of up to 300,000 shares of common stock.
• Termination date of the plan: Oct 21, 2026.

Why it may matter This disclosure was reported under Item 8.01 (Other events), which covers events the company chose to report outside the specific item categories of the Form 8-K, in this case the termination of a previously disclosed Rule 10b5-1 trading arrangement. A filing does not show why the insider traded or why the company acted.